Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]

Yin P, Li H, Ke C, et al. Int J Nanomedicine. 2020;15:1499—1515. The authors have advised Figure 5A on page 1511 is incorrect. Due to an error at the time of figure assembly day 21 Au@PP/poly(I:C)+TMZ and day 28 Au@PP/poly(I:C)+TMZ in the HE 200× row were duplic...

Full description

Bibliographic Details
Main Authors: Yin P, Li H, Ke C, Cao G, Xin X, Hu J, Cai X, Li L, Liu X, Du B
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/corrigendum-intranasal-delivery-of-immunotherapeutic-nanoformulations--peer-reviewed-article-IJN
id doaj-1e396a273c2e474395861374f3f7c4e7
record_format Article
spelling doaj-1e396a273c2e474395861374f3f7c4e72020-12-02T18:37:41ZengDove Medical PressInternational Journal of Nanomedicine1178-20132020-11-01Volume 158873887459169Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]Yin PLi HKe CCao GXin XHu JCai XLi LLiu XDu BYin P, Li H, Ke C, et al. Int J Nanomedicine. 2020;15:1499—1515. The authors have advised Figure 5A on page 1511 is incorrect. Due to an error at the time of figure assembly day 21 Au@PP/poly(I:C)+TMZ and day 28 Au@PP/poly(I:C)+TMZ in the HE 200× row were duplicated. The correct Figure 5 is shown below.   The authors apologize for this error and advise it does not affect the results of the paper.   Read the original article  https://www.dovepress.com/corrigendum-intranasal-delivery-of-immunotherapeutic-nanoformulations--peer-reviewed-article-IJNaunpspoly (i:c)intranasal administrationimmunogenic cell deathin situ immune response activation
collection DOAJ
language English
format Article
sources DOAJ
author Yin P
Li H
Ke C
Cao G
Xin X
Hu J
Cai X
Li L
Liu X
Du B
spellingShingle Yin P
Li H
Ke C
Cao G
Xin X
Hu J
Cai X
Li L
Liu X
Du B
Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
International Journal of Nanomedicine
aunps
poly (i:c)
intranasal administration
immunogenic cell death
in situ immune response activation
author_facet Yin P
Li H
Ke C
Cao G
Xin X
Hu J
Cai X
Li L
Liu X
Du B
author_sort Yin P
title Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
title_short Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
title_full Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
title_fullStr Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
title_full_unstemmed Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
title_sort intranasal delivery of immunotherapeutic nanoformulations for treatment of glioma through in situ activation of immune response [corrigendum]
publisher Dove Medical Press
series International Journal of Nanomedicine
issn 1178-2013
publishDate 2020-11-01
description Yin P, Li H, Ke C, et al. Int J Nanomedicine. 2020;15:1499—1515. The authors have advised Figure 5A on page 1511 is incorrect. Due to an error at the time of figure assembly day 21 Au@PP/poly(I:C)+TMZ and day 28 Au@PP/poly(I:C)+TMZ in the HE 200× row were duplicated. The correct Figure 5 is shown below.   The authors apologize for this error and advise it does not affect the results of the paper.   Read the original article  
topic aunps
poly (i:c)
intranasal administration
immunogenic cell death
in situ immune response activation
url https://www.dovepress.com/corrigendum-intranasal-delivery-of-immunotherapeutic-nanoformulations--peer-reviewed-article-IJN
work_keys_str_mv AT yinp intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum
AT lih intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum
AT kec intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum
AT caog intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum
AT xinx intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum
AT huj intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum
AT caix intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum
AT lil intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum
AT liux intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum
AT dub intranasaldeliveryofimmunotherapeuticnanoformulationsfortreatmentofgliomathroughinsituactivationofimmuneresponsecorrigendum
_version_ 1724403429128798208